News

If you own CVS Health (CVS), the primary focus shifts from 2026 execution toward potential headwind variables heading into 2027. Management raised its 2026 earnings outlook on its fiscal Q2 2026 call in August. It also gave an early read on 2027, a quarter sooner than usual. One warning in that read came with no number. Over the past three months, the shares lost 15.2%, while the S&P 500 gained 5.0%. What is the 2027 problem CVS would not put a number on.

Jodee Kozlak, a veteran of major multinational corporations, will join UnitedHealth this coming Monday to modernize and align the healthcare behemoth’s operations across its various businesses.

Most beginners chase the highest yield they can find and end up owning a ticking time bomb. One fund built around a completely different logic has quietly turned $2,000 starting positions into compounding income machines for over a decade.

Key TakeawaysUnitedHealth’s commercial segment cost trend ran modestly above 11% in the first half of 2026, with roughly 100 basis points tied to arbitration abuse and provider coding intensity, the same billing dynamic a new Blue Cross Blue Shield Association study says cost insurers $942 million industry wide over two years. Management pushed commercial margin recovery past 2027, a full year later than planned, even as the consolidated medical care ratio improved to 86.

By Exec Edge Editorial Staff Health insurance premiums have climbed for years. Deductibles have climbed right along with them. Yet a growing number of American households are choosing neither, opting instead for a decades-old alternative, which is not health insurance, built around monthly contributions and community values. “People are clearly paying high premiums now,” Liberty […] The post Liberty HealthShare’s Dorsey Morrow Makes the Financial Case for Healthsharing on Becker’s Healthcare Pod

UnitedHealth Group (UNH) stock has risen about 40% since late March 2026, against close to 19% for the S&P 500. Read cold, that looks like a recovery nobody could have timed. It was not hidden. The company had said plainly, months before the shares turned, that it would give up members to rebuild margin.

Molina Healthcare's Medicaid recovery, Medicare duals growth and contract wins support a focused turnaround story, positioning it ahead of UnitedHealth.

UnitedHealth Group has seen its share price deliver mixed results in recent years, with shorter term gains sitting alongside a longer multi year decline. That uneven share price path puts the spotlight on a simple question for investors who follow UnitedHealth Group stock: whether the current valuation is backed up by its earnings power. Over the past 3 years the stock has declined 21.4%, which puts more weight on whether the earnings profile justifies where the shares trade today. Recent...

In the closing of the recent trading day, UnitedHealth Group (UNH) stood at $372.8, denoting a -1.26% move from the preceding trading day.

UnitedHealth (UNH) has turned its profits around. Operating earnings rose 55% in the second quarter of 2026, and management raised its full-year adjusted earnings guide to $19.50 to $20 a share. Revenue, though, has nearly stopped growing. So the rest of the recovery rests on something the company only partly controls: the medical bills of the people it insures.

CI is expanding AI across care coordination and specialty pharmacy as it seeks to manage elevated healthcare costs and improve access.

CNC's profitability is recovering, but rising margins face a key test as Medicaid membership declines and eligibility reviews continue.

UnitedHealth (UNH) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

When the Federal Reserve lifts rates and signals they may stay elevated for years, the easy-growth playbook breaks. Cash flows today matter more than promises tomorrow, and investors start to care a lot about balance sheet strength, pricing power and dependable dividends. This article walks through three large cap quality defensive stocks that screen well under those rules and explains how the latest Fed move could affect each one. The three stocks below are a sample of what this quality...

UnitedHealth is staging a turnaround after raising full-year adjusted EPS guidance. The firm also pays an annualized dividend of $9.28 with a yield above 2.4%.

UnitedHealth's repair job is going to plan almost everywhere. The exception is the cost of its commercial health plans, where medical costs are running modestly above the 11% the company had been expecting. Medicare costs are coming in below what it planned for 2026, and Medicaid cost trend is in line, though management expects Medicaid margins to stay pressured for 2026. That cost divergence is what a holder should watch.

Healthcare stocks Eli Lilly, UnitedHealth Group, and Johnson & Johnson offer options for investors of different ages, combining growth potential, turnaround momentum, and reliable dividends.

Auxier Asset Management, an investment advisory firm, released its second-quarter 2026 investor letter. The letter can be downloaded here. Following a strong rebound from the first-quarter decline, the S&P 500 gained 15.2% as accelerating capital spending toward artificial intelligence infrastructure drove significant gains across technology hardware companies. Semiconductor and data-center-related businesses benefited from supply constraints […]

Walmart, UnitedHealth and Wells Fargo highlight resilient growth, while XMax and Interlink pursue expansion despite execution challenges.

UnitedHealth, Dell and Goldman Sachs headline a week of rate decisions, rising commodity inflation and global political uncertainty.

CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.

The health care giant showered its owners with cash, yet the stock spent years in the slow lane. Here’s the accounting of what that trade-off actually delivered.

Walmart's omnichannel strength, UnitedHealth's raised 2026 EPS outlook and Wells Fargo's asset-cap removal highlight today's reports.

Optum Health hit a wall due to rising costs and restrictive Medicare Advantage payments.

THC's shares are gaining on higher-acuity demand, strong commercial revenues and USPI's continued expansion.

UnitedHealth (UNH) has been facing investor questions surrounding the upcoming release of Medicare A

UnitedHealth Group Inc (NYSE:UNH) recently announced a total dividend of $2.32 per share, with the ex-dividend date set for 2026-09-14. This amount consists of $2.32 per share in cash dividends, payable on 2026-09-22. Investors should note that the ex-dividend date of 2026-09-14 means shareholders must own the stock before that date to qualify for the payment.

A static dividend yield quietly loses ground every month inflation climbs, but five companies have been raising their payouts fast enough to fight back. The question is which ones have the cash flow to keep doing it.

UnitedHealth is removing prior-authorization hurdles for 1,700 services. Less paperwork sounds great, but what does it mean for UNH investors?

Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financial discipline.